Market Place
Sourcing Support
PharmaMar says potential COVID-19 treatment shows efficacy against Omicron
10 Jan 2022 //
REUTERS
PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19
29 Jan 2021 //
PMLIVE
PharmaMar plans phase III trial of cancer drug for COVID-19, shares jump
15 Oct 2020 //
REUTERS
Boryung , PharmaMar’s partner in South Korea, announces superior potent results
02 Jul 2020 //
PHARMAMAR.COM/WP-CONTENT/UPLOADS/2020/07
Scientists Tested 47 Existing Drugs And Found Potential New Ways to Fight Covid
04 May 2020 //
SCIENCEALERT
PharmaMar Has Announced That the Spanish Medicines Agency Aplidin® (Plitidepsin)
29 Apr 2020 //
YAHOO
PharmaMar Has Announced the Spanish Medicines Agency Has Authorized APLICOV-PC
27 Apr 2020 //
PR NEWSWIRE
PharmaMar Signs a Commercialization & Distrib. License Agreement for Aplidin®
11 Jun 2018 //
PR NEWSWIRE
Six medicines recommended for approval, including one orphan
24 Mar 2018 //
EMA
PharmaMar signs a marketing & distribution license agreement with Megapharm
02 Jan 2018 //
PR NEWSWIRE
Seven medicines recommended for approval, including an advanced therapy
16 Dec 2017 //
EMA
Plitidepsin (PharmaMar) Shows Activity Against the Cells Responsible
12 Dec 2017 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.